Thomas Zimmer, Conference Chair, Senior Vice President, Boehringer Ingelheim GmbH, said: “Megatrends in the pharmaceutical industry are in front of us. There is an increased focus on quality risk management, good compliance practices, flexible facilities using modular concepts, the use of disposables for quality risk management and on the right implementation of quality by design — not to mention the important topic of supply chain integrity and the upcoming new GDPs. More and more, these topics need to be addressed with a cross-functional approach.”
The three conference tracks — Operations, Facilities and Plants and IT and Automation — will explore the implications of flexible and adaptable manufacturing for pharmaceutical production, including:
• supply chain requirements
• the use of disposables in aseptic manufacture
• lean production
• portable equipment and modular plants
• innovative technologies and control strategies
• process data applications.
The conference will also cover the expected changes to the GMP chapters 3 and 5 and their impact on facility design and production as well as recommendations to avoid cross contamination in a shared production facility.
For more information on this conference, including detailed agendas and registration information, visit: www.ISPE.org/2013-Flexible-Facilities-EU-Conference.